Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michael O. Kayatta"'
Autor:
Bradley G. Leshnower, Michael O. Kayatta, Jose N. Binongo, LaRonica McPherson, Edward P. Chen, Yi Lasanajak
Publikováno v:
The Annals of Thoracic Surgery. 107:499-504
Background Standard therapy for aortic root dilation in the setting of bicuspid aortic valves remains use of a composite valve conduit. The long-term durability of valve-sparing root replacement (VSRR) in bicuspid aortopathy is presently unclear. In
Autor:
LaRonica McPherson, Michael O. Kayatta, Chao Zhang, Bradley G. Leshnower, Yi Lasanajak, Edward P. Chen
Publikováno v:
The Annals of Thoracic Surgery. 107:54-60
Valve-sparing aortic root replacement (VSRR) is an established treatment for aortic root pathology for trileaflet valves. The safety and durability of VSRR in bicuspid aortopathy is unclear. In this study, outcomes of performing VSRR in the setting o
Publikováno v:
State of the Art Surgical Coronary Revascularization
Traditionally, the treatment of coronary artery disease has been divided among medical therapy, percutaneous coronary intervention, or coronary artery bypass grafting. However, with hybrid coronary revascularization (HCR), both percutaneous coronary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1428ea0227cd5d72dee3699b49d0a29
https://doi.org/10.1093/med/9780198758785.003.0062
https://doi.org/10.1093/med/9780198758785.003.0062
Publikováno v:
Annals of Cardiothoracic Surgery. 7:500-505
Coronary artery disease (CAD) has typically been treated either medically, with percutaneous coronary intervention (PCI), or with coronary artery bypass grafting (CABG). As advances in stent technology and minimally invasive surgery have developed, a
Autor:
Michael O. Kayatta, Edward P. Chen
Publikováno v:
General Thoracic and Cardiovascular Surgery. 64:639-650
Hypothermic circulatory arrest is a critical component of aortic arch procedures, without which these operations could not be safely performed. Despite the use of hypothermia as a protective adjunct for organ preservation, aortic arch surgery remains
Autor:
Michael O. Kayatta, Michael E. Halkos
Publikováno v:
Expert Review of Cardiovascular Therapy. 14:821-830
Two main approaches to myocardial revascularization currently exist, coronary artery bypass and percutaneous coronary intervention. In patients with advanced coronary artery disease, coronary artery bypass surgery is associated with improved long ter
Autor:
Michael O. Kayatta, Michael E. Halkos
Publikováno v:
Indian J Thorac Cardiovasc Surg
PURPOSE: Hybrid coronary revascularization is an emerging treatment strategy for coronary artery disease. We will review the reasons for the development of this strategy, describe surgical techniques, and review outcomes. Finally, we will discuss the
Autor:
Kreton Mavromatis, Bradley G. Leshnower, Robert A. Guyton, Amy Simone, Vasilis Babaliaros, Jose C. Condado, Peter C. Block, Michael O. Kayatta, Patrick D. Kilgo, James Stewart, Vinod H. Thourani, Patricia Keegan, Eric L. Sarin, Chun Li, Chandan Devireddy, Stamatios Lerakis, Hanna A. Jensen
Publikováno v:
The Annals of Thoracic Surgery. 100:1261-1267
Background Transcatheter aortic valve replacement (TAVR) may offer extreme-aged patients a treatment alternative to surgical aortic valve replacement (SAVR). The objective of this study was to describe outcomes of TAVR in nonagenarians using transfem
Autor:
Michael O. Kayatta, Richard C. Gilmore, Hanna A. Jensen, Muralidhar Padala, Vinod H. Thourani
Publikováno v:
Interventional Cardiology. 6:557-567
Mitral valve regurgitation is a common disease, traditionally treated with valve repair or replacement using open cardiac surgery. The most common etiologies of mitral regurgitation (MR) include degenerative and functional pathologies. MitraClip® (A
Autor:
Vinod H. Thourani, Amjad Syed, Jose F. Condado, Michael O. Kayatta, Richard C. Gilmore, Bradley G. Leshnower, Eric L. Sarin, Hanna A. Jensen, Vasilis Babaliaros, Mohammad H. Rajaei
Publikováno v:
Innovations (Philadelphia, Pa.). 11(4)
Transcatheter aortic valve replacement as an alternative to open surgical repair is rapidly becoming more used in high-risk patients with aortic stenosis. Transcatheter aortic valve replacement offers the benefit of being much less invasive than trad